---
figid: PMC3227936__onc0021005460001
figtitle: EGFR signaling pathway
organisms:
- Homo sapiens
pmcid: PMC3227936
filename: onc0021005460001.jpg
figlink: /pmc/articles/PMC3227936/figure/F1/
number: F1
caption: 'EGFR signaling pathway. Ligands bind to EGFR and stimulate dimerization
  of the receptor. RAS is, in turn, activated, stimulating both the PI3K–AKT and RAF–MEK–MAPK
  pathways, resulting in cell proliferation, survival, and invasion.Abbreviations:
  EGFR, epidermal growth factor receptor; GRB2, growth factor receptor-bound protein
  2; HB-EGF, heparin-binding EGF-like growth factor; MAPK, mitogen-activated protein
  kinase; MEK, MAPK/extracellular signal–related kinase kinase; PI3K, phosphatidylinositol-3-kinase;
  SOS, son of sevenless; TGF-α, transforming growth factor α.Reprinted from Raponi
  M, Winkler H, Dracopoli NC. KRAS mutations predict response to EGFR inhibitors.
  Curr Opin Pharmacol 2008;8:413–418, copyright 2008, with permission from Elsevier.'
papertitle: 'Predicting Response to EGFR Inhibitors in Metastatic Colorectal Cancer:
  Current Practice and Future Directions.'
reftext: Veena Shankaran, et al. Oncologist. 2010 Feb;15(2):157-167.
year: '2010'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9301267
figid_alias: PMC3227936__F1
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC3227936__F1
ndex: ee90699d-df0a-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3227936__onc0021005460001.html
  '@type': Dataset
  description: 'EGFR signaling pathway. Ligands bind to EGFR and stimulate dimerization
    of the receptor. RAS is, in turn, activated, stimulating both the PI3K–AKT and
    RAF–MEK–MAPK pathways, resulting in cell proliferation, survival, and invasion.Abbreviations:
    EGFR, epidermal growth factor receptor; GRB2, growth factor receptor-bound protein
    2; HB-EGF, heparin-binding EGF-like growth factor; MAPK, mitogen-activated protein
    kinase; MEK, MAPK/extracellular signal–related kinase kinase; PI3K, phosphatidylinositol-3-kinase;
    SOS, son of sevenless; TGF-α, transforming growth factor α.Reprinted from Raponi
    M, Winkler H, Dracopoli NC. KRAS mutations predict response to EGFR inhibitors.
    Curr Opin Pharmacol 2008;8:413–418, copyright 2008, with permission from Elsevier.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EGF
  - TGFA
  - HBEGF
  - GRB2
  - XYLT2
  - SOS1
  - SOS2
  - KRAS
  - HRAS
  - NRAS
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - AKT1
  - AKT2
  - AKT3
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
